• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于识别P-糖蛋白底物的计算整合药效团模型。

A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.

作者信息

Penzotti Julie E, Lamb Michelle L, Evensen Erik, Grootenhuis Peter D J

出版信息

J Med Chem. 2002 Apr 25;45(9):1737-40. doi: 10.1021/jm0255062.

DOI:10.1021/jm0255062
PMID:11960484
Abstract

P-glycoprotein (P-gp) functions as a drug efflux pump, mediating multidrug resistance and limiting the efficacy of many drugs. Clearly, identification of potential P-gp substrate liability early in the drug discovery process would be advantageous. We describe a multiple-pharmacophore model that can discriminate between substrates and nonsubstrates of P-gp with an accuracy of 63%. The application of this filter allows large virtual libraries to be screened efficiently for compounds less likely to be transported by P-gp.

摘要

P-糖蛋白(P-gp)作为一种药物外排泵,介导多药耐药性并限制许多药物的疗效。显然,在药物发现过程的早期识别潜在的P-gp底物倾向将是有利的。我们描述了一种多药效团模型,该模型能够以63%的准确率区分P-gp的底物和非底物。应用此筛选方法可有效筛选大型虚拟库,以找出不太可能被P-gp转运的化合物。

相似文献

1
A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.一种用于识别P-糖蛋白底物的计算整合药效团模型。
J Med Chem. 2002 Apr 25;45(9):1737-40. doi: 10.1021/jm0255062.
2
Computational models for identifying potential P-glycoprotein substrates and inhibitors.用于识别潜在P-糖蛋白底物和抑制剂的计算模型。
Mol Pharm. 2006 Jan-Feb;3(1):33-44. doi: 10.1021/mp050071a.
3
P-glycoprotein recognition of substrates and circumvention through rational drug design.P-糖蛋白对底物的识别以及通过合理药物设计实现规避
Mol Pharm. 2006 Jan-Feb;3(1):3-25. doi: 10.1021/mp0500871.
4
Predicting P-glycoprotein-mediated drug transport based on support vector machine and three-dimensional crystal structure of P-glycoprotein.基于支持向量机和 P-糖蛋白三维晶体结构预测 P-糖蛋白介导的药物转运。
PLoS One. 2011;6(10):e25815. doi: 10.1371/journal.pone.0025815. Epub 2011 Oct 4.
5
Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison.P-糖蛋白与多药耐药相关蛋白MRP1的底物识别:比较
Int J Clin Pharmacol Ther. 2000 Mar;38(3):111-21. doi: 10.5414/cpp38111.
6
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).参与P-糖蛋白多药耐药的药物的药效团模型:结构多样性的解释(假说)。
J Med Chem. 2002 Dec 19;45(26):5671-86. doi: 10.1021/jm020941h.
7
Use of shape similarities for the classification of P-glycoprotein substrates and nonsubstrates.利用形状相似性对 P-糖蛋白底物和非底物进行分类。
Future Med Chem. 2011 Jul;3(9):1117-28. doi: 10.4155/fmc.11.58.
8
The structure and functions of P-glycoprotein.P-糖蛋白的结构与功能。
Curr Med Chem. 2010;17(8):786-800. doi: 10.2174/092986710790514507.
9
Prediction of promiscuous p-glycoprotein inhibition using a novel machine learning scheme.使用新型机器学习方案预测潜在的 P-糖蛋白抑制剂。
PLoS One. 2012;7(3):e33829. doi: 10.1371/journal.pone.0033829. Epub 2012 Mar 16.
10
Multiclass Classifier for P-Glycoprotein Substrates, Inhibitors, and Non-Active Compounds.多类 P-糖蛋白底物、抑制剂和非活性化合物分类器。
Molecules. 2019 May 25;24(10):2006. doi: 10.3390/molecules24102006.

引用本文的文献

1
Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules.评估小分子进入中枢神经系统的实验和计算方法。
Molecules. 2024 Mar 13;29(6):1264. doi: 10.3390/molecules29061264.
2
Development of a Hierarchical Support Vector Regression-Based In Silico Model for Caco-2 Permeability.基于分层支持向量回归的Caco-2通透性计算机模拟模型的开发
Pharmaceutics. 2021 Jan 28;13(2):174. doi: 10.3390/pharmaceutics13020174.
3
Theoretical Prediction of the Complex P-Glycoprotein Substrate Efflux Based on the Novel Hierarchical Support Vector Regression Scheme.
基于新型分层支持向量回归方案的复杂 P 糖蛋白底物外排的理论预测。
Molecules. 2018 Jul 22;23(7):1820. doi: 10.3390/molecules23071820.
4
P-glycoprotein transporter in drug development.药物研发中的P-糖蛋白转运体
EXCLI J. 2016 Feb 12;15:113-8. doi: 10.17179/excli2015-768. eCollection 2016.
5
Classification of P-glycoprotein-interacting compounds using machine learning methods.使用机器学习方法对P-糖蛋白相互作用化合物进行分类
EXCLI J. 2015 Aug 19;14:958-70. doi: 10.17179/excli2015-374. eCollection 2015.
6
Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.基于药效团的人脑血管内皮hCMEC/D3细胞系新型药物/质子反向转运体抑制剂的发现
Br J Pharmacol. 2015 Oct;172(20):4888-904. doi: 10.1111/bph.13258. Epub 2015 Oct 13.
7
Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists.四取代吡啶作为强效5-HT2C受体激动剂的设计、合成与评价
ACS Med Chem Lett. 2015 Jan 20;6(3):329-33. doi: 10.1021/ml500507v. eCollection 2015 Mar 12.
8
Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.P-糖蛋白(ABCB1)多特异性的分子基础:近期的生化与结构研究
Adv Cancer Res. 2015;125:71-96. doi: 10.1016/bs.acr.2014.10.003. Epub 2015 Jan 8.
9
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.药物类化合物中P-糖蛋白介导的外排倾向的从头预测。
ACS Med Chem Lett. 2012 Nov 6;4(1):108-12. doi: 10.1021/ml300314h. eCollection 2013 Jan 10.
10
Pharmacophore modeling of nilotinib as an inhibitor of ATP-binding cassette drug transporters and BCR-ABL kinase using a three-dimensional quantitative structure-activity relationship approach.使用三维定量构效关系方法对尼罗替尼作为ATP结合盒式药物转运体和BCR-ABL激酶抑制剂进行药效团建模。
Mol Pharm. 2014 Jul 7;11(7):2313-22. doi: 10.1021/mp400762h. Epub 2014 Jun 5.